Understanding Amyotrophic Lateral Sclerosis (ALS)
41 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary cause of Amyotrophic Lateral Sclerosis (ALS)?

  • Sporadic and environmental factors (correct)
  • Genetic factors
  • Viral infections
  • Autoimmune disorders
  • What is the average life expectancy after the onset of Amyotrophic Lateral Sclerosis?

  • 5-10 years
  • 3-5 years (correct)
  • 10-15 years
  • 1-2 years
  • Which gender is more affected by Multiple Sclerosis?

  • Men
  • Transgender individuals
  • Women (correct)
  • Equal in both genders
  • Which of the following is NOT a common functional impairment in ALS?

    <p>Cognitive decline</p> Signup and view all the answers

    Which diagnostic method is specifically used to assess nerve conduction speeds?

    <p>Nerve conduction study</p> Signup and view all the answers

    What is a significant complication of ALS that can lead to death?

    <p>Respiratory failure</p> Signup and view all the answers

    What therapeutic role does a therapist play for ALS patients?

    <p>Helping with transfers and equipment education</p> Signup and view all the answers

    What factor is associated with an increased risk of Multiple Sclerosis?

    <p>Obesity and smoking</p> Signup and view all the answers

    What is a common complication associated with muscular dystrophy?

    <p>Respiratory complications</p> Signup and view all the answers

    Which type of muscular dystrophy typically presents with an onset at age 5-10 and a slower progression of muscle fiber destruction?

    <p>Beckers MD</p> Signup and view all the answers

    Which of the following statements is true about the role of the therapeutic assistant in managing muscular dystrophy?

    <p>They educate on KAFOs and energy conservation.</p> Signup and view all the answers

    What is the genetic inheritance pattern of Duchenne's muscular dystrophy?

    <p>X-linked recessive</p> Signup and view all the answers

    Which symptom is least associated with multiple sclerosis (MS)?

    <p>Rapid weight loss</p> Signup and view all the answers

    Which of the following is a defining characteristic of the Grower's maneuver in muscular dystrophy?

    <p>Hands-on thighs to assist in standing</p> Signup and view all the answers

    What muscle condition is characterized by muscle weakness and an inability to relax muscles, often leading to cardiac issues and cataracts?

    <p>Myotonic MD</p> Signup and view all the answers

    Which treatment approach is not typically recommended for managing spasticity?

    <p>Increased physical exertion without guidance</p> Signup and view all the answers

    Which statement accurately describes the difference between Duchenne's and Becker's muscular dystrophy?

    <p>Duchenne's MD leads to complete absence of dystrophin.</p> Signup and view all the answers

    Which of the following is NOT a type of multiple sclerosis?

    <p>Chronic progressive</p> Signup and view all the answers

    What is the expected life expectancy for someone with Duchenne's muscular dystrophy without treatment?

    <p>Teens</p> Signup and view all the answers

    Which statement about Uhthoff's phenomenon is true?

    <p>It can exacerbate MS symptoms.</p> Signup and view all the answers

    What mechanism causes muscle stiffness due to spasticity?

    <p>Tonic stretch reflexes.</p> Signup and view all the answers

    What is a potential complication of untreated spasticity?

    <p>Chronic pain.</p> Signup and view all the answers

    Which aspect of cognitive changes in MS patients is most frequently observed?

    <p>Difficulty in understanding new concepts.</p> Signup and view all the answers

    In patients with spasticity, which sign is NOT commonly observed?

    <p>Increased muscle atrophy.</p> Signup and view all the answers

    When identifying MS treatment needs, which educational approach is least appropriate?

    <p>Encouragement to avoid social connections.</p> Signup and view all the answers

    Which demographic is most likely to develop Parkinson's disease?

    <p>Men aged 65 or older.</p> Signup and view all the answers

    What is a hallmark sign of Parkinson's Disease that indicates a change in movement?

    <p>Rigidity</p> Signup and view all the answers

    Which of the following symptoms is common in Progressive Supranuclear Palsy but not in Parkinson's Disease?

    <p>Difficulty swallowing</p> Signup and view all the answers

    Huntington's Disease is primarily caused by a mutation in which of the following?

    <p>Huntingtin gene</p> Signup and view all the answers

    What type of motor symptom is characterized by slow or no movement and difficulty initiating motion in Parkinson's Disease?

    <p>Bradykinesia</p> Signup and view all the answers

    Which treatment approach is common for managing symptoms of Huntington's Disease?

    <p>Anti-psychotics</p> Signup and view all the answers

    Which of the following is NOT a common complication associated with Progressive Supranuclear Palsy?

    <p>Weight loss</p> Signup and view all the answers

    In Charcot-Marie-Tooth Disorder, the first symptoms often include weakness in which body parts?

    <p>Hands and feet</p> Signup and view all the answers

    What aspect of mobility is particularly affected in patients with Parkinson's Disease?

    <p>Decreased arm swing</p> Signup and view all the answers

    Which treatment strategy is specifically highlighted for use in Parkinson's Disease to help with movement?

    <p>Deep brain stimulation</p> Signup and view all the answers

    Which symptom is associated with both Huntington's Disease and Progressive Supranuclear Palsy?

    <p>Cognitive decline</p> Signup and view all the answers

    Which of the following describes a potential complication from significant mobility challenges found in Progressive Supranuclear Palsy?

    <p>Head injuries</p> Signup and view all the answers

    Which symptom is linked to decreased proprioception in Charcot-Marie-Tooth Disorder?

    <p>Difficulty walking</p> Signup and view all the answers

    The mutation in Charcot-Marie-Tooth Disorder primarily affects which part of the nervous system?

    <p>Peripheral nervous system</p> Signup and view all the answers

    Which mental health symptom is characteristic of Huntington's Disease?

    <p>Mood swings</p> Signup and view all the answers

    What is the focus of therapeutic education provided for patients with Charcot-Marie-Tooth Disorder?

    <p>Equipment adjustment and repair</p> Signup and view all the answers

    Study Notes

    Amyotrophic Lateral Sclerosis (ALS)

    • Etiology: 5-10% genetic; 90-95% sporadic (oxidative stress or immune abnormality).
    • Life Expectancy: 3-5 years from onset.
    • Mean Age Onset: 57 years.
    • Gender Prevalence: Men are affected 1.5-2 times more frequently.
    • Diagnosis: Electromyogram, gene testing, nerve conduction studies.
    • Pathophysiology: Death of upper motor neurons (UMN) and lower motor neurons (LMN) leads to muscle atrophy and eventual loss of function in speaking, eating, breathing, and mobility.
    • Signs and Symptoms: Muscle weakness, fasciculations, swallowing/speech difficulties (if corticobulbar involved), cognition initially unaffected but risk for dementia later, spasticity.
    • Possible Complications: Respiratory failure, pneumonia.
    • Functional Impairments: Loss of mobility, inability to speak, inability to walk.
    • Treatment Approaches: No cure; medications manage symptoms (pain, sleep disturbance, spasticity, fatigue, saliva).
    • Therapeutic Assistant (TA) Role: Transfers, positioning, environmental adaptations, equipment education to patients and families, equipment provision, maintaining range of motion (ROM) and strength, mental health support.

    Multiple Sclerosis (MS)

    • Etiology: Unknown; genetic predisposition, infection triggers, abnormal immune response (inflammation and CNS damage), obesity, smoking, low vitamin D, geography, and environmental factors.
    • Life Expectancy: Minimal change; significant impact on quality of life.
    • Mean Age Onset: 32; typically between 20-50 years of age.
    • Gender Prevalence: Women are affected 3 times more frequently.
    • Pathophysiology: Immune-mediated disease attacking the Central Nervous System (CNS); inflammation damages myelin sheath and axons, slowing or preventing message transmission.
    • Signs and Symptoms: Initial symptoms include bladder dysfunction, walking problems, and vision issues; also bowel dysfunction, MS hug (dysesthesia), spasticity, numbness/tingling, pain/itching, vertigo, emotional changes (mood swings), cognitive changes (short-term memory, learning, slow processing), depression, fatigue (worsens with heat/humidity). Less common: taste/hearing loss, breathing issues, tremors, speech/swallowing issues.
    • Possible Complications: Suicide, severe fatigue, chronic pain, falls, seizures.
    • Functional Impairments: Inability to walk, inability to see.
    • Treatment Approaches: Modify disease, treat relapses, manage symptoms, promote function, provide support (emotional), find MS care provider.
    • TA Role: Assistive aids (showering, energy conservation), assistive aids (cooking, energy conservation), environmental modifications, education on relapses/remissions, mobility equipment, exercise programs, social connections (online groups).
    • Definitions: Uhthoff's phenomenon (exacerbation of symptoms with heat), clinically isolated syndrome, relapsing-remitting, primary progressive, secondary progressive.

    Spasticity

    • Etiology: Upper motor neuron (UMN) lesion; velocity-dependent increase in tonic stretch reflexes.
    • Signs and Symptoms: Joint/muscle stiffness, exaggerated muscle jerks, abnormal posture/position, pain.
    • Possible Complications: Skin breakdown, pain, permanent muscle shortening.
    • Functional Impairments: Inability to walk, self-feed, dress, drive.
    • Treatment Approaches: Maintain muscle length, relaxation techniques (knowing triggers), medications (baclofen, botulinum toxin), functional electrical stimulation (FES).
    • TA Role: Education on positioning, splint use, exercises for active and passive range of motion (A/PROM).
    • Definitions: UMN lesion vs. LMN lesion characteristics, tone, rigidity, flexor spasticity, clonus spasticity, spastic paralysis, flaccid paralysis.

    Parkinson's Disease

    • Etiology: Unknown; likely a combination of genetic and environmental factors. Increased risk with age.
    • Mean Age Onset: 65; 10% onset before 50.
    • Gender Prevalence: Men are affected 1.5 times more frequently.
    • Diagnosis: Alpha-synuclein misshapen protein clumps (Lewy bodies) accumulate in the substantia nigra, slowing dopamine production.
    • Signs and Symptoms: Rigidity, bradykinesia/akinesia, resting tremor, decreased arm swing, poor balance, festination, freezing, stooped posture, difficulty standing/turning, dysarthria/hypophonia, mask-like face, micrographia, anxiety, depression, apathy, hallucinations, delusions, sleep disturbances, fatigue, loss of sense of smell, cognitive decline.
    • Possible Complications: Falls, head trauma, suicide.
    • Functional Impairments: Difficulty walking, sleeping, social interaction.
    • Treatment Approaches: Medications (dopamine), surgery (deep brain stimulation), exercise, complementary therapies, bilateral movements, mental rehearsal.
    • TA Role: Exercise programs, balance work, maintaining ADLs, gait training (visual, auditory, kinesthetic aids).

    Progressive Supranuclear Palsy (PSP)

    • Etiology: Faster progression than Parkinson's; onset in late middle age. Abnormal protein tau accumulation in brain regions causes neuron death.
    • Signs and Symptoms: Difficulty walking, loss of balance, difficulty swallowing, slowed/slurred/monotone speech, slow eye movements, difficulty looking up/down, eye lid control issues, involuntary eye closing, decreased blinking/difficulty opening, head movements instead of eye movements, depression, lack of motivation, changes in judgment, insight, problem-solving, apathy, irritability, sudden laughing/crying/anger, personality changes, mask-like face, sleep problems.
    • Possible Complications: Pneumonia, choking, head injuries.
    • Functional Impairments: Falls, mobility, difficulty with transfers, feeding/dressing/driving, social interaction, safety risks due to cognition changes.
    • Treatment Approaches: Botox for eye symptoms, antidepressants.
    • TA Role: Aids and education, exercise programs, compensatory strategies.

    Huntington's Disease

    • Etiology: Mutation in the huntingtin gene causes brain cell death.
    • Onset: Middle age.
    • Life Expectancy: 15-20 years after onset.
    • Signs and Symptoms: Clumsiness, postural instability, chorea, muscle rigidity, apathy, inability to concentrate, depression, mood swings, psychosis, cognitive decline, dementia, speech difficulties, swallowing difficulties, weight loss, tremors, insomnia, fatigue, seizures.
    • Possible Complications: Pneumonia, suicide, extreme weight loss, violence.
    • Functional Impairments: Safety risks, strained relationships, loss of speech/walking/feeding/driving, bed bound.
    • Treatment Approaches: Antipsychotics/antidepressants, pre-birth testing, mobility aids, fall prevention, assistive devices, harm reduction, seating/positioning.
    • TA Role: Mobility/provision and education, fall prevention, equipment adjustment, repair.

    Charcot-Marie-Tooth Disease (CMT)

    • Etiology: Mutation in genes supporting proteins of the peripheral nervous system (PNS); damage to axons/myelin sheath affecting long nerves first.
    • Signs and Symptoms: Initial weakness in hands, feet, arms, legs, reduced muscle bulk/reflexes, sensory loss, foot/orthotic issues, progressive paralysis, high-stepped gait, balance issues, inverted champagne bottle shaped legs, reduced senses, difficulty with fine motor, diminished proprioception, hip displacement, contractures, nerve pain, fatigue, hearing loss.
    • Possible Complications: Chronic pain, deformities from muscle imbalance, swallowing/breathing issues.
    • Functional Impairments: Falls, loss of independence in ADLs, safety risks, reduced socialization due to hearing loss.
    • Treatment Approaches: Hearing aids, orthopedic surgery, medications, pain relief, splinting (AFOs, hand/finger), exercises (maintain strength/ROM/cardio), assistive devices.
    • TA Role: Splinting fitting, exercise programs, assistive device provision and education.

    Muscular Dystrophy (MD)

    • Etiology: Group of genetic myopathies; primarily affecting men; hereditary X-linked (females are carriers). Dystrophin protein production is abnormal/insufficient.
    • Life Expectancy: Without treatment, adolescence; with treatment, 20-30s.
    • Pathophysiology: Duchenne's MD (no dystrophin): Rapid muscle fiber destruction and replacement by fat/scar tissue. Becker's MD (abnormal dystrophin): Slower muscle fiber destruction.
    • Duchenne's MD Progression: Gradual loss of fine/gross motor skills, muscle weakness, wheelchair dependence, non-invasive ventilator, cardiac/respiratory complications.
    • Signs and Symptoms: Delayed developmental milestones, falls, pseudohypertrophy of calves, abnormal gait, Gowers maneuver, anxiety, depression. Specific gait characteristics include shoulder back, belly forward, foot drop, Achilles tendon contracture, thick calves, locked knees, weak glutes.
    • Possible Complications: Falls, pneumonia, cardiac issues, pressure sores.
    • Psychosocial Considerations: Parental distress, child realization, transition challenges.
    • Functional Impairments: Headaches, sleep disturbances, loss of mobility, ADL limitations, fatigue.
    • Treatment Approaches: Respiratory exercises, ROM exercises, wheelchair fitting, energy conservation, KAFOs.
    • TA Role: KAFO education, exercises, energy conservation techniques.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) with this quiz. Explore causes, symptoms, life expectancy, and therapeutic roles related to these neurological disorders. Perfect for students or anyone interested in learning more about these conditions.

    More Like This

    ALS/MS
    34 questions

    ALS/MS

    FormidableEiffelTower avatar
    FormidableEiffelTower
    Amyotrophic Lateral Sclerosis (ALS)
    10 questions
    Use Quizgecko on...
    Browser
    Browser